TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Jul 22, 2021 08:00 JST
Source:
Science and Technology of Advanced Materials
Stimulating blood vessel formation with magnets
Magnetic field could boost blood vessel growth to regenerate damaged tissue.
TSUKUBA, Japan, Jul 22, 2021 - (ACN Newswire) - Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. The findings, by researchers at the Tecnico Lisboa and NOVA School of Science and Technology in Portugal, could lead to new treatments for cancers and help regenerate tissues that have lost their blood supply.
"Researchers have found it challenging to develop functional, vascularized tissue that can be implanted or used to regenerate damaged blood vessels," says Frederico Ferreira, a bioengineer at Tecnico Lisboa's Institute for Biosciences and Bioengineering. "We developed a promising cell therapy alternative that can non-invasively stimulate blood vessel formation or regeneration through the application of an external low-intensity magnetic field."
Human-donated mesenchymal stromal cells were placed on PVA or gelatin hydrogels containing iron oxide nanoparticles. Applying a magnetic field to the gelatin hydrogel triggered the release of VEGF-A. This was used to treat endothelial cells, stimulating blood vessel formation.
The researchers worked with human mesenchymal stromal cells from bone marrow. These cells can change into different cell types, and also secrete a protein called VEGF-A that stimulates blood vessel formation.
Ana Carina Manjua and Carla Portugal, at the Research Centre LAQV at the NOVA School of Science and Technology, developed two hydrogel supports, made from polyvinyl alcohol (PVA) or gelatin, both containing iron oxide nanoparticles. Cells were cultured on the hydrogels and exposed to a low-intensity magnetic field for 24 hours.
The cells on the PVA hydrogel produced less VEGF-A after the magnetic treatment. But the cells on the gelatin hydrogel produced more. Subsequent lab tests showed that this VEGF-A rich extracts, taken from the cultures on magnet-stimulated gelatin hydrogel, improved the ability of human vascular endothelial cells to sprout into branching blood vessel networks.
Endothelial cells were then placed onto a culture dish with a gap separating them. The conditioned media from magnet-treated mesenchymal stromal cells from the gelatin hydrogel were added to the endothelial cells, moving to close the gap between them in 20 hours. This was significantly faster than the 30 hours they needed when they had not received magnetic treatment. Placing a magnet directly below the dish triggered the mesenchymal stromal cells to close the gap in just four hours.
Finally, VEGF-A extracts produced by magnet-treated mesenchymal stromal cells on gelatin increased blood vessel formation in a chick embryo, although further research is needed to confirm these results.
More work is needed to understand what happens at the molecular level when a magnetic field is applied to the cells. But the researchers say gelatin hydrogels containing iron oxide nanoparticles and mesenchymal stromal cells could one day be applied to damaged blood vessels and then exposed to a short magnetic treatment to heal them.
The team suggests that magnet-treated cells on PVA, which produce less of the growth factor, could be used to slow down blood vessel growth to limit the expansion of cancer cells.
Further information
Frederico Castelo Ferreira
Universidade de Lisboa
Email:
frederico.ferreira@ist.utl.pt
Carla Portugal
Universidade Nova de Lisboa
Email:
cmp@fct.unl.pt
Ana Carina Baeta Manjua
Universidade de Lisboa
Email:
carina.manjua@tecnico.ulisboa.pt
About Science and Technology of Advanced Materials Journal
Open access journal STAM publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials. Website:
https://www.tandfonline.com/toc/tsta20/current
Dr. Yoshikazu Shinohara
STAM Publishing Director
Email:
SHINOHARA.Yoshikazu@nims.go.jp
Press release distributed by ResearchSEA for Science and Technology of Advanced Materials.
Source: Science and Technology of Advanced Materials
Sectors: Science & Nanotech, BioTech
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Machine learning can predict the mechanical properties of polymers
October 25 2024 23:00 JST
Dual-action therapy shows promise against aggressive oral cancer
July 30 2024 20:00 JST
A new spin on materials analysis
April 17 2024 22:00 JST
Kirigami hydrogels rise from cellulose film
April 12 2024 18:00 JST
Sensing structure without touching
February 27 2024 08:00 JST
Nano-sized probes reveal how cellular structure responds to pressure
November 21 2023 07:00 JST
Machine learning techniques improve X-ray materials analysis
November 17 2023 10:00 JST
A bio-inspired twist on robotic handling
November 14 2023 20:00 JST
GPT-4 artificial intelligence shows some competence in chemistry
October 17 2023 08:00 JST
Closing the loop between artificial intelligence and robotic experiments
August 24 2023 09:00 JST
More Press release >>
Latest Press Release
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST
ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST
Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST
Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST
COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST
Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism
Nov 15, 2024 12:32 JST
Fujitsu collaborates with global suppliers in decarbonization initiative to exchange product-level primary data on CO2 emissions
Nov 15, 2024 10:13 JST
TANAKA Successfully Develops the World's First[1] Manufacturing Technology for Platinum Materials with Nano-Sized Crystal Grains
Nov 15, 2024 04:00 JST
More Latest Release >>